Wegovy(Semaglutide)
Clinically proven GLP-1 medication delivering up to 21% weight loss with significant cardiovascular benefits.
Up to 21%
Weight Loss
Once Weekly
Convenient
20% Reduction
CV Risk
FDA Approved
Proven Safe
How Wegovy Works
Appetite Regulation
Activates GLP-1 receptors to reduce hunger and increase feelings of fullness.
Slows Digestion
Helps you feel satisfied longer by slowing the movement of food through your stomach.
Blood Sugar Control
Improves insulin secretion and helps maintain healthy blood sugar levels.
Cardiovascular Protection
Clinical studies show 20% reduced cardiovascular risk in adults with heart disease.
Clinical Results
- Average 15-21% body weight reduction over 68 weeks in clinical trials
- 83% of participants lost 5% or more of their body weight
- 20% reduction in major cardiovascular events in high-risk patients
- Significant improvements in blood pressure, cholesterol, and HbA1c levels
Side Effects & Safety Information
Common Side Effects
Most side effects are mild and typically improve over time:
- Nausea
- Diarrhoea
- Vomiting
- Constipation
- Abdominal pain
- Headache
- Fatigue
- Dizziness
When to Seek Medical Attention
- • Severe stomach pain that will not go away
- • Vision changes or severe eye pain
- • Rapid heartbeat or palpitations
- • Symptoms of pancreatitis
- • Signs of allergic reaction (rash, swelling, breathing difficulty)
Dosing Schedule
Wegovy is gradually increased over 16-20 weeks to the maintenance dose:
Weeks 1-4: 0.25mg once weekly
Initial dose
Weeks 5-8: 0.5mg once weekly
First increase
Weeks 9-12: 1mg once weekly
Second increase
Weeks 13-16: 1.7mg once weekly
Third increase
Week 17+: 2.4mg once weekly
Maintenance dose
Frequently Asked Questions
Discover if Wegovy Is Right for You
Complete our health assessment to receive personalised treatment recommendations.